Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Voedsellevering, toezicht op afstand en door coaching ondersteund onderwijs voor geoptimaliseerd diabetesbeheer (FREEDOM) (FREEDOM)

18 september 2026 bijgewerkt door: Tapan Shirish Mehta, University of Alabama at Birmingham

Brief Summary:

The FREEDOM study aims to develop a scalable intervention to improve type 2 diabetes mellitus control in low-income Black adults in the Deep South. The intervention targets social determinants of health (SDoH) such as reduced healthcare access, poverty, transportation barriers, and food insecurity.

Studie Overzicht

Gedetailleerde beschrijving

Detailed Description:

  1. FREEDOM Study (Type 2 Diabetes Mellitus):

    The FREEDOM study is a 12-month clinical trial enrolling 304 Black adults with Type 2 Diabetes Mellitus across three healthcare systems in Alabama and Mississippi. Participants are randomly assigned to one of eight combinations of three intervention components:

    • Digital Health Coaching: Participants receive one-on-one phone-based coaching for optimized diabetes management.
    • Food Box Delivery: Food boxes are delivered every two weeks to participants' homes,
    • Remote Patient Monitoring (RPM): Participants receive essential supplies, including glucometers, for remote blood glucose measurement. Data is monitored remotely for timely interventions.

    The study involves three in-person visits at baseline, month 6, and month 12, as well as two telephone study check-ins at month 3 and 9. Survey packets are administered at each time point.

  2. FREEDOM-HIV Study (Type 2 Diabetes Mellitus and HIV Cohort):

Additionally, a cohort within the study, known as the FREEDOM-HIV study, will enroll additional 80 adults who have both Type 2 Diabetes Mellitus and HIV. This cohort will be observed over a 6-month period and will also consist of the same three intervention components.

Studietype

Ingrijpend

Inschrijving (Werkelijk)

304

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

    • Alabama
      • Birmingham, Alabama, Verenigde Staten, 35205
        • UAB Hospital and UMMC Cardiology Clinics

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

18 jaar en ouder (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion criteria:

  1. Self-identified as Black/African American
  2. ICD diagnosis of T2DM
  3. ≥18 years of age
  4. Ongoing insulin treatment
  5. HbA1c ≥8% within 6 weeks of study screening
  6. has the ability to converse in and read English
  7. must provide written informed consent prior to enrollment

Exclusion criteria:

  1. Current enrollment in any diabetes-related interventional study
  2. Cognitive impairment
  3. End-stage kidney disease (CKD-5)
  4. Pregnant or plans to become pregnant within 12 months
  5. Currently enrolled in a structured lifestyle change program
  6. Enrolled in remote patient monitoring or health coaching within 60 days of the study or intervention

HIV Cohort Criteria

Inclusion Criteria

  1. ≥ 18 years of age
  2. ICD diagnosis of T2DM
  3. HbA1c ≥ 7%
  4. Confirmed HIV+ diagnosis
  5. Prescribed HIV ART therapy as part of care

Exclusion Criteria

  1. Current enrollment in any diabetes-related interventional study or structured lifestyle change program
  2. Enrolled in RPM or health coaching (except for coaching on smoking cessation) within 60 days of the intervention
  3. Cognitive impairment
  4. End-stage kidney disease (CKD-5)
  5. Pregnant or plans to become pregnant within 12 months

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Ondersteunende zorg
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Faculteitstoewijzing
  • Masker: Enkel

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Arm 1

Digital coaching+ Food delivery+ RPM

The digital health coaching intervention program involves an evidence-based curriculum and one-on-one support to promote positive health behaviors and patient self-management of diabetes.

The food box intervention component will consist of biweekly food boxes delivered directly to participants over the course of 6 months. The food boxes will contain shelf-stable groceries that adhere to ADA nutritional guidelines for individuals with T2DM.

The RPM team will instruct the participants to monitor blood glucose levels 3 times daily. Glucose levels will be monitored 8 a.m. to 5 p.m.Monday to Friday. Data summaries will be reviewed bi-monthly with RNs and pharmacists. Participants will be provided with a glucometer, test strips, and mobile divide to record their blood glucose levels.

The diabetes education class will be administered by a certified diabetes educator.

Actieve vergelijker: Arm 2

Digital coaching

The digital health coaching intervention program involves an evidence-based curriculum and one-on-one support to promote positive health behaviors and patient self-management of diabetes.

The diabetes education class will be administered by a certified diabetes educator.

Actieve vergelijker: Arm 3

Digital coaching+ Food delivery

The digital health coaching intervention program involves an evidence-based curriculum and one-on-one support to promote positive health behaviors and patient self-management of diabetes.

The food box intervention component will consist of biweekly food boxes delivered directly to participants over the course of 6 months. The food boxes will contain shelf-stable groceries that adhere to ADA nutritional guidelines for individuals with T2DM.

The diabetes education class will be administered by a certified diabetes educator.

Actieve vergelijker: Arm 4

Digital coaching+ RPM

The digital health coaching intervention program involves an evidence-based curriculum and one-on-one support to promote positive health behaviors and patient self-management of diabetes.

The RPM team will instruct the participants to monitor blood glucose levels 3 times daily. Glucose levels will be monitored 8 a.m. to 5 p.m.Monday to Friday. Data summaries will be reviewed bi-monthly with RNs and pharmacists. Participants will be provided with a glucometer, test strips, and mobile divide to record their blood glucose levels.

The diabetes education class will be administered by a certified diabetes educator.

Actieve vergelijker: Arm 5

Food delivery+ RPM

The food box intervention component will consist of biweekly food boxes delivered directly to participants over the course of 6 months. The food boxes will contain shelf-stable groceries that adhere to ADA nutritional guidelines for individuals with T2DM.

The RPM team will instruct the participants to monitor blood glucose levels 3 times daily. Glucose levels will be monitored 8 a.m. to 5 p.m.Monday to Friday. Data summaries will be reviewed bi-monthly with RNs and pharmacists. Participants will be provided with a glucometer, test strips, and mobile divide to record their blood glucose levels.

The diabetes education class will be administered by a certified diabetes educator.

Actieve vergelijker: Arm 6

The participant's will not receive any Intervention

The diabetes education class will be administered by a certified diabetes educator.

Actieve vergelijker: Arm 7

Food delivery

The food box intervention component will consist of biweekly food boxes delivered directly to participants over the course of 6 months. The food boxes will contain shelf-stable groceries that adhere to ADA nutritional guidelines for individuals with T2DM.

The diabetes education class will be administered by a certified diabetes educator.

Actieve vergelijker: Arm 8

RPM

The RPM team will instruct the participants to monitor blood glucose levels 3 times daily. Glucose levels will be monitored 8 a.m. to 5 p.m.Monday to Friday. Data summaries will be reviewed bi-monthly with RNs and pharmacists. Participants will be provided with a glucometer, test strips, and mobile divide to record their blood glucose levels.

The diabetes education class will be administered by a certified diabetes educator.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
FREEDOM Study: Change in HbA1c level between baseline and 12 month
Tijdsspanne: 12 months

The primary outcome of the study is to track change in the HbA1c between baseline and 12 months (endpoint of the study). The HbA1C will be tested at baseline, 6 and 12 months.

12 months
Primary Outcome for the HIV Cohort: Change in HbA1c level between baseline and 6 months
Tijdsspanne: 6 months

The primary outcome of the study is to track change in the HbA1c between baseline and 6 months (endpoint of the study). The HbA1C will be tested at baseline and 6 months.

6 months

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

5 januari 2023

Primaire voltooiing (Werkelijk)

21 juli 2026

Studie voltooiing (Werkelijk)

30 augustus 2026

Studieregistratiedata

Eerst ingediend

17 februari 2022

Eerst ingediend dat voldeed aan de QC-criteria

10 maart 2022

Eerst geplaatst (Werkelijk)

21 maart 2022

Updates van studierecords

Laatste update geplaatst (Werkelijk)

22 september 2026

Laatste update ingediend die voldeed aan QC-criteria

18 september 2026

Laatst geverifieerd

1 september 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren